The quick take-away on California’s Senator Scott Weiner bill SB 1012’s passing out of the Business and Professions Committee is that we have proposed legislation that creates
- a new licensing Board, called the Board of Psychedelic Facilitators under the Department of Consumer Affairs, “which will license and regulate professional facilitators trained in psychedelic-assisted therapy”
- for people older than 21
- use will be required to be supervised — presumably in clinical spaces, yet to be elaborated
- covers the substances
- psilocybin/psilocyn (mushrooms),
- Dimethyltryptamine (“DMT,” the active ingredient in ayahuasca),
- MDMA, and
- mescaline (other than peyote)
- substances will be required to be tested by a licensed entity
- facilitators will be required to possess an existing professional health license, such as psychiatrists, licensed clinical social workers, drug & alcohol counselors, and nurse practitioners
- sponsored by the Heroic Hearts Project, Law Enforcement Action Partnership (LEAP), and Veterans Exploring Treatment Solutions (VETS)
This development reflects momentum for increased access for psychedelics without creating a suddenly open market.
Oregon just RE-criminalized psychedelics along with other drugs, after the 2020 ballot initiative Ballot Measure 110 was reversed by Oregon’s House Bill 4002, which goes into effect in September 2024, making it about 3.5 years that Oregon’s experiment will have lasted.
Noteworthy on SB-1012:
- No, ketamine is not on the list
- What will be considered appropriate training for facilitators has yet to be defined and apparently that will be handled by the Regulated Psychedelic Substances Advisory Committee
We’re still examining the details of the proposed legislations, and we’ll have more analysis as we break it down.
Leave a Reply